Related Experiment Video
Updated: May 5, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
Medical clinics versus usual care for patients with both diabetes and hypertension: a randomized trial
David Edelman1, Sonja K Fredrickson, Stephanie D Melnyk
1Durham Veterans Affairs Medical Center, Durham, North Carolina 27705, USA. dedelman@duke.edu <dedelman@duke.edu>
Insights
Group medical clinics effectively lower blood pressure in patients with diabetes and hypertension. However, they did not significantly improve hemoglobin A1c levels compared to usual care.
Area of Science:
- Internal Medicine
- Clinical Research
- Health Services Research
Background:
- Group medical clinics (GMCs) are utilized for managing diabetes and hypertension.
- Limited data exist on the effectiveness of GMCs for these conditions.
Purpose of the Study:
- To evaluate the efficacy of GMCs in managing comorbid diabetes and hypertension.
- To compare GMCs against usual care for these chronic conditions.
Main Methods:
- A randomized controlled trial involving 239 patients with poorly controlled diabetes and hypertension.
- Patients were assigned to either GMCs or usual care at two Veterans Affairs Medical Centers.
- Intervention involved structured group sessions with a multidisciplinary team, with medication adjustments to manage HbA1c and blood pressure.
Main Results:
- Mean systolic blood pressure improved significantly more in the GMC group (13.7 mm Hg) than in the usual care group (6.4 mm Hg) (P=0.011).
- Mean hemoglobin A1c (HbA1c) levels improved in both groups (0.8% in GMC, 0.5% in usual care), with no statistically significant difference between them (P=0.159).
Conclusions:
- Group medical clinics demonstrate effectiveness in improving blood pressure control for diabetic patients.
- GMCs did not show a significant benefit over usual care in improving HbA1c levels.
- Concomitant improvements in the usual care group may have influenced the study's outcome measurements.
Background:
Group medical clinics (GMCs) are widely used in the management of diabetes and hypertension, but data on their effectiveness are limited.
Objective:
To test the effectiveness of GMCs in the management of comorbid diabetes and hypertension.
Design:
Randomized, controlled trial. (ClinicalTrials.gov registration number: NCT00286741)
Setting:
2 Veterans Affairs Medical Centers in North Carolina and Virginia.
Patients:
239 patients with poorly controlled diabetes (hemoglobin A(1c) [HbA(1c)] level > or =7.5%) and hypertension (systolic blood pressure >140 mm Hg or diastolic blood pressure >90 mm Hg).
Intervention:
Patients were randomly assigned within each center to either attend a GMC or receive usual care. Clinics comprised 7 to 8 patients and a care team that consisted of a primary care general internist, a pharmacist, and a nurse or other certified diabetes educator. Each session included structured group interactions moderated by the educator. The pharmacist and physician adjusted medication to manage each patient's HbA(1c) level and blood pressure.
Measurements:
Hemoglobin A(1c) level and systolic blood pressure, measured by blinded research personnel at baseline, study midpoint (median, 6.8 months), and study completion (median follow-up, 12.8 months). Linear mixed models, adjusted for clustering within GMCs, were used to compare HbA(1c) levels and systolic blood pressure between the intervention and control groups.
Results:
Mean baseline systolic blood pressure and HbA(1c) level were 152.9 mm Hg (SD, 14.2) and 9.2% (SD, 1.4), respectively. At the end of the study, mean systolic blood pressure improved by 13.7 mm Hg in the GMC group and 6.4 mm Hg in the usual care group (P = 0.011 by linear mixed model), whereas mean HbA(1c) level improved by 0.8% in the GMC group and 0.5% in the usual care group (P = 0.159).
Limitation:
Measurements of effectiveness may have been limited by concomitant improvements in the usual care group that were due to co-intervention.
Conclusion:
Group medical clinics are a potent strategy for improving blood pressure but not HbA(1c) level in diabetic patients.
Primary Funding Source:
U.S. Department of Veterans Affairs Health Services Research and Development Service.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

